Category: FDA

Brand and Trademark Monitoring in Social Media · brand confusion · Business Consultant Singapore · Business News · Competition Commission of India (CCI) · Competition Laws in India · Data Protection · Entrepreneur · Entrepreneurs · Entrepreneurship · Equity · FDA · incorporate legal entity · India Business Guide · initial public offering (IPO) · Intellectual Property · Intellectual Property India · Intellectual Property strategy · Legal Issues · Licensing & Syndication · Pharmaceutical Industry In India · Possible Legal Issues · Regenerative Medicine Patent · Start New Business in India · Venture Capital Funding · Venture Capital Investments

Changes in Share Capital in Accordance with The Companies Act, 2013

Rahul Dev

Main Changes in Company’s Share Capital | Shares at a Discount | Preference Shares for More Than 20 years | Private Placement, Bonus Shares and GDRs | Alteration of Share Capital | Consolidation and Division of Shares

Angel Investors · Basics of patent drafting · Biotechnology · Brand and Trademark Monitoring in Social Media · Branding the Startups · Business Consultant in Singapore · Business Consultant Singapore · Business Due Diligence Report · Business Idea | Patent · Business in India · Business Plan Consultant · Buying or Selling a Website · Competition Commission of India (CCI) · competition law expert · Competition Laws in India · Confidentiality · Contract Drafting Law Firm in India · Data Protection · Doing Business in India · Entrepreneur · Entrepreneurs · Entrepreneurship · Equity · FDA · initial public offering (IPO) · Intellectual Property India · Intellectual Property strategy · IP due-diligence · IPR Funding · Licensing & Syndication · Patent VC funding · Patenting Big Data · Pharmaceutical Industry In India · Possible Legal Issues · protecting business idea · Singapore data protection law · Start ups · technology funding · Trademarks and Venture Capital Investments · Venture Capital Investments · Venture Capitalists

Directors And Their Powers in Accordance with The Companies Act, 2013

Rahul Dev

Directors And Their Powers | Maximum Number Of Directors | Maximum Number Of Directorship | Composition Of Board | Resignation Of Director | Vacancy Of Office For Not Attending Board Meetings | Disclosures In Board’s Report | Special Resolution

Biosimilar Drug Regulations · biosimilar product development · Biotechnology · Business News · Drug Patent Expiration · FDA · innovator drug licensed in India · Legal News · Patent Expirations & Biosimilar Drug Regulations · Patent Regulatory Guidelines in India · Pharmaceutical Industry In India · Pharmaceutical patent attorney

Patent Expirations & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India

Rahul DevLeave a comment

Earlier this year, in Feb. 2012, FDA issued draft guidance on biosimilar product development, and The Patient Protection and Affordable Care Act, which was signed into law by President Obama on March 23, 2010, amended the Public Health Service Act to create an abbreviated approval pathway -- under section 351(k) -- for biological products that… Continue reading Patent Expirations & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India